Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on April 29, 2025
Axiom Medical Marks 25 Years of Advancing Workplace Safety and Health at Annual Client Summit
GlobeNewswire
·
April 29, 2025
HOUSTON, TX, April 29, 2025 (GLOBE NEWSWIRE) -- Axiom Medical, a leader in occupational health and workplace injury case management solutions, celebrated 25 years of protecting workers and supporting employers at its 2025 Client Summit. Held in the Houston …
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
GlobeNewswire
·
April 29, 2025
An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly demonstrates that higher drug exposure (above median) leads to improved objective response rate (33.3% vs 5.6%) and longer …
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025
GlobeNewswire
·
April 29, 2025
– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of gene therapies – – Current pipeline of gene therapies for chronic diseases spans three major …
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
GlobeNewswire
·
April 29, 2025
VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery, today …
Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases
GlobeNewswire
·
April 29, 2025
- Novel approach to treat neurodegenerative diseases by targeting fibrin-driven neuroinflammation was well-tolerated among healthy volunteers, with a clean hematological profile - - Half-life supports once-monthly dosing - - Data to be presented at AAIC 25 …
Yaqrit 将于 5 月 7 日至 10 日在欧洲肝脏研究协会 (EASL) 大会上展示其临床进展
GlobeNewswire
·
April 29, 2025
分享的数据为其在肝性脑病、急性慢性肝衰竭 (ACLF) 和失代偿性肝硬化领域的关键高级临床试验提供重要支持 管理层将出席此次会议 伦敦, April 29, 2025 (GLOBE NEWSWIRE) -- Yaqrit 是一家处于临床研究后期的公司，致力于开发治疗晚期肝病的救命疗法。该公司今日宣布，将在于 5 月 7 日至 10 日在阿姆斯特丹举行的欧洲肝脏研究协会 (EASL) 大会上与投资者、临床和科学同行分享其进展。 Yaqrit …
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
GlobeNewswire
·
April 29, 2025
MCLEAN, Va., April 29, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today …
Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
FibroBiologics Presenting at the ThymUS 2025 Meeting
GlobeNewswire
·
April 29, 2025
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
GlobeNewswire
·
April 29, 2025
Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer-killing CD8+ T Cells and limiting immune evasion by tumor cells TNX-1700 is in preclinical development for gastric and colorectal cancers CHATHAM, N.J., April …
WeightWatchers Streamlines Member Access to Zepbound® Vials with LillyDirect® Pharmacy Provider
GlobeNewswire
·
April 29, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”), the global leader in science-backed weight management, today announced a pharmacy integration with Eli Lilly and Company’s LillyDirect® …
Best Probiotics For Weight Loss: Top Rated Probiotic Supplements For Belly Fat & Menopause Women Over 50 – WOLFSON BRANDS (UK) LIMITED
GlobeNewswire
·
April 29, 2025
Glasgow, April 29, 2025 (GLOBE NEWSWIRE) -- Whenever there is a reference to health or well-being, probiotics will be commonly mentioned. Multiple natural probiotics exist, all claiming to heal all ailments. Probiotics are currently trendy and aid in …
Best Legal Steroids for Muscle Growth, Fat Loss, and Strength: Top Natural Alternatives to Anabolic Steroids For Sale (By CrazyBulk)
GlobeNewswire
·
April 29, 2025
New York City, April 29, 2025 (GLOBE NEWSWIRE) -- If you’re serious about building muscle mass, shredding fat, and unlocking peak physical performance — without risking your health — then legal steroid alternatives could be your ultimate game-changer. …
YMCA of the USA Urges Families to Participate in “Phones Down, Eyes Up™” This Summer
GlobeNewswire
·
April 29, 2025
CHICAGO, April 29, 2025 (GLOBE NEWSWIRE) -- YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to announce the launch of its new national water safety campaign Phones Down, Eyes Up™ featuring a new …
Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 29, 2025
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2025 earnings conference call at 4:30 pm EDT on Tuesday, May 6, 2025. The …
Muscular Dystrophy Association Launches National ALS Awareness Campaign to Accelerate the Search for a Cure
GlobeNewswire
·
April 29, 2025
New York, April 29, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the launch of its nationwide campaign focused on amyotrophic lateral sclerosis (ALS) during ALS Awareness Month in May, honoring a powerful legacy that …
USA Today Names HealthEquity to its Top 25 Workplaces
GlobeNewswire
·
April 29, 2025
DRAPER, Utah, April 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation’s largest health savings account (HSA) administrator, today announced it has been named a USA Today Top Workplace for 2025, ranking 23rd …
Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments
GlobeNewswire
·
April 29, 2025
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter study that demonstrated significant and sustained pain relief more than four years after treatment with 60-day …
“Planting the Conversation” for Mental Health Awareness Month
GlobeNewswire
·
April 29, 2025
DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- As mental health challenges continue to rise in workplaces globally, “Gardenuity for Business,” the B2B wellness solution from Gardenuity, is scaling its efforts to help companies care for their teams. Donna …
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
GlobeNewswire
·
April 29, 2025
Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA Breakthrough Device Designations The Virtue Trial will be …